Article Details
Retrieved on: 2021-11-18 14:36:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Xevudy, developed by U.S. company Vir Biotechnology Inc. and Britain-based GlaxoSmithKline, is a so-called monoclonal antibody treatment — a ...
Article found on: apnews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here